• print
  • mail
  • Home
  • Media
  • Press Releases

  • Overview
  • Fact Sheets
  • Featured Content
  • Press Releases
  • Abgenix Press Release Archives
  • Tularik Press Release Archives
  • Immunex Press Release Archives
  • Media Contacts
  • In the News
  • Virtual Press Kits
Press Release Library
2009   |    2008   |    2007   |    2006   |    2005   |    2004   |    2003   |    2002


Date Title
Feb. 8, 2010 Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases
Jan. 25, 2010 Amgen's Fourth Quarter 2009 Adjusted Earnings Per Share Decreased 1 Percent to $1.05; Full Year 2009 Adjusted Earnings Per Share Increased 8 Percent to $4.91
Jan. 21, 2010 Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium
Jan. 20, 2010 Amgen Announces Webcast of 2009 Fourth Quarter and Full Year Financial Results
Jan. 14, 2010 Amgen Donates $2 Million, Establishes Earthquake Relief Program
Jan. 7, 2010 Amgen to Present at the 28th Annual JP Morgan Healthcare Conference
footer